Category: News
-
Atuka moves into North America’s largest urban innovation hub
In a significant moment for Atuka, we have completed the move into our new offices and facilities in the MaRS Discovery District in Toronto.
-
Atuka, 유전자 치료의 미래를 다룬 최신 백서 발간
Building on Atuka’s pioneering work in Parkinson’s disease and other neurodegenerative disorders, this paper lays out the transformative potential of gene therapy.
-
Kannalife Sciences 및 Michael J. Fox Foundation과의 150만 달러 규모 협력 발표
The grant will fund preclinical research of Kannalife Science’s KLS-13019, a synthetic cannabinoid therapeutic which offers great promise for Parkinson’s disease.
-
Atuka, 신임 이사로 이안 레녹스(Ian Lennox) 영입
As Atuka expands beyond its traditional base in Parkinson’s research, we look forward to Lennox’s contributions as a pioneering executive with decades of experience as an innovator in our sector.
